theophylline extended-release tablets
bryant ranch prepack - theophylline anhydrous (unii: 0i55128jyk) (theophylline anhydrous - unii:0i55128jyk) - theophylline anhydrous 200 mg - theophylline extended-release tablets are indicated for the treatment of the symptoms and reversible airflow obstruction associated with chronic asthma and other chronic lung diseases, e.g., emphysema and chronic bronchitis. theophylline extended-release tablets are contraindicated in patients with a history of hypersensitivity to theophylline or other components in the product.
theophylline- theophylline, anhydrous capsule, extended release
inwood laboratories, inc. - theophylline, anhydrous (unii: 0i55128jyk) (theophylline, anhydrous - unii:0i55128jyk) - capsule, extended release - 125 mg - theophylline extended-release capsules are indicated for the treatment of the symptoms and reversible airflow obstruction associated with chronic asthma and other chronic lung diseases, e.g., emphysema and chronic bronchitis. theophylline extended - release capsules is contraindicated in patients with a history of hypersensitivity to theophylline or other components in the product.
theophylline anhydrous- theophylline tablet, extended release
bryant ranch prepack - theophylline anhydrous (unii: 0i55128jyk) (theophylline anhydrous - unii:0i55128jyk) - theophylline anhydrous 400 mg - theophylline is indicated for the treatment of the symptoms and reversible airflow obstruction associated with chronic asthma and other chronic lung diseases, e.g., emphysema and chronic bronchitis. theophylline (anhydrous) extended-release tablets are contraindicated in patients with a history of hypersensitivity to theophylline or other components in the product.
theophylline (anhydrous)- theophylline tablet, extended release
carilion materials management - theophylline anhydrous (unii: 0i55128jyk) (theophylline anhydrous - unii:0i55128jyk) - theophylline anhydrous 600 mg - theophylline is indicated for the treatment of the symptoms and reversible airflow obstruction associated with chronic asthma and other chronic lung diseases, e.g., emphysema and chronic bronchitis. theophylline (anhydrous) extended-release tablets are contraindicated in patients with a history of hypersensitivity to theophylline or other components in the product.
theophylline tablet, extended release
carilion materials management - theophylline anhydrous (unii: 0i55128jyk) (theophylline anhydrous - unii:0i55128jyk) - theophylline anhydrous 300 mg - theophylline extended-release tablets are indicated for the treatment of the symptoms and reversible airflow obstruction associated with chronic asthma and other chronic lung diseases, e.g., emphysema and chronic bronchitis. theophylline extended-release tablets are contraindicated in patients with a history of hypersensitivity to theophylline or other components in the product.
aminophylline injection solution
american regent laboratories, inc. - aminophylline (unii: 27y3kjk423) (aminophylline - unii:27y3kjk423) - 25 mg in 1 ml
aminophylline hydrate 25mg/ml solution for injection
mercury pharmaceuticals (ireland) limited 4045 kingswood road, city west business park, co, dublin, ireland - aminophylline hydrate - solution for injection - aminophylline hydrate 25 mg/ml - drugs for obstructive airway diseases
aminophylline hydrate 25mg/ml solution for injection
mercury pharmaceuticals (ireland) ltd - aminophylline hydrate - solution for injection - 25 milligram(s)/millilitre - xanthines; aminophylline
theophylline in dextrose injection solution
hospira, inc. - theophylline anhydrous (unii: 0i55128jyk) (theophylline anhydrous - unii:0i55128jyk) - theophylline anhydrous 160 mg in 100 ml
aminophylline s.a.l.f 240 mg10 ml
raz pharmaceutics ltd, israel - theophylline ethylenediamine dehydrate - concentrate for solution for infusion - theophylline ethylenediamine dehydrate 240 mg / 10 ml - theophylline - - bronchial asthma;- pulmonary affections with bronchial spastic component.